Back to results
US 12,642,874 B2Granted
Methods of treating eye diseases
AssigneeVisgenx, Inc.
InventorsChristopher Chavez, Martin Emanuele
Life of this patent
Estimating the term…
Abstract
Disclosed herein are therapeutic agents capable of increasing the expression level of ELOVL2. Also described herein are therapeutic agents that reduce or slow an aging phenotype. Methods for treating age-related eye diseases or conditions are also provided. Methods for treating an age-related eye disease or condition in a subject by administering one or more therapeutic agents are provided.
Claims13
A method of treating age-related macular degeneration (AMD), comprising:
- administering a composition comprising a polynucleotide sequence comprising SEQ ID NO:
- 3 to the eye of a subject, wherein the polynucleotide is operably linked to a promoter and administered to the eye by an intravitreal or subretinal injection.
Dependencies are inferred from the claim text.